Free Trial
OTCMKTS:IPATF

ImmunoPrecise Antibodies (IPATF) Stock Price, News & Analysis

ImmunoPrecise Antibodies logo
$0.56 +0.02 (+4.53%)
As of 05/28/2025

About ImmunoPrecise Antibodies Stock (OTCMKTS:IPATF)

Key Stats

Today's Range
$0.54
$0.56
50-Day Range
$0.36
$0.56
52-Week Range
$1.15
$20.25
Volume
193,932 shs
Average Volume
20,327 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Receive IPATF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.

IPATF Stock News Headlines

ImmunoPrecise Antibodies: Q2 Earnings Insights
Midnight trade alert: After-hours spike incoming???
Most traders don’t realize this… But the closing bell means jack $#!&. They hear the bell and they think “time to go”... But when Tim Sykes hears the bell?
Immunoprecise Antibodies Ltd (IPA)
See More Headlines

IPATF Stock Analysis - Frequently Asked Questions

ImmunoPrecise Antibodies' stock was trading at $0.41 at the start of the year. Since then, IPATF shares have increased by 36.1% and is now trading at $0.5582.
View the best growth stocks for 2025 here
.

Shares of IPATF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:IPATF
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:IPATF) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners